Evolent Health Operating Income 2014-2025 | EVH
Evolent Health operating income from 2014 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
Evolent Health Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-40 |
| 2023 | $-71 |
| 2022 | $4 |
| 2021 | $-42 |
| 2020 | $-263 |
| 2019 | $-309 |
| 2018 | $-47 |
| 2017 | $-73 |
| 2016 | $-237 |
| 2015 | $-43 |
| 2014 | |
| 2013 | $-21 |
|
Evolent Health Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $1 |
| 2025-06-30 | $-1 |
| 2025-03-31 | $-2 |
| 2024-12-31 | $-19 |
| 2024-09-30 | $-16 |
| 2024-06-30 | $8 |
| 2024-03-31 | $-13 |
| 2023-12-31 | $-21 |
| 2023-09-30 | $-18 |
| 2023-06-30 | $-22 |
| 2023-03-31 | $-10 |
| 2022-12-31 | $-2 |
| 2022-09-30 | $13 |
| 2022-06-30 | $-5 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-12 |
| 2021-09-30 | $-7 |
| 2021-06-30 | $-8 |
| 2021-03-31 | $-16 |
| 2020-12-31 | $5 |
| 2020-09-30 | $-16 |
| 2020-06-30 | $-226 |
| 2020-03-31 | $-25 |
| 2019-12-31 | $-217 |
| 2019-09-30 | $-20 |
| 2019-06-30 | $-25 |
| 2019-03-31 | $-47 |
| 2018-12-31 | $-13 |
| 2018-09-30 | $-11 |
| 2018-06-30 | $-9 |
| 2018-03-31 | $-14 |
| 2017-12-31 | $-18 |
| 2017-09-30 | $-14 |
| 2017-06-30 | $-19 |
| 2017-03-31 | $-21 |
| 2016-12-31 | $-34 |
| 2016-09-30 | $-16 |
| 2016-06-30 | $-13 |
| 2016-03-31 | $-175 |
| 2015-12-31 | $-14 |
| 2015-09-30 | $-17 |
| 2015-06-30 | $-12 |
| 2015-03-31 | |
| 2014-12-31 | $12 |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | $-12 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.432B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.404B | 55.40 |
| Tempus AI (TEM) | United States | $11.811B | 0.00 |
| Doximity (DOCS) | United States | $8.862B | 36.49 |
| Hims & Hers Health (HIMS) | United States | $8.100B | 65.89 |
| IRhythm Technologies (IRTC) | United States | $5.397B | 0.00 |
| Hinge Health (HNGE) | United States | $3.215B | 0.00 |
| Privia Health (PRVA) | United States | $2.856B | 178.62 |
| Inspire Medical Systems (INSP) | United States | $2.466B | 40.80 |
| Heartflow (HTFL) | United States | $2.248B | 0.00 |
| 10x Genomics (TXG) | United States | $1.987B | 0.00 |
| Enovis (ENOV) | United States | $1.618B | 8.50 |
| Omnicell (OMCL) | United States | $1.534B | 31.37 |
| Azenta (AZTA) | United States | $1.346B | 58.74 |
| Schrodinger (SDGR) | United States | $1.286B | 0.00 |
| Phreesia (PHR) | United States | $1.234B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.214B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.891B | 0.00 |
| Claritev (CTEV) | United States | $0.630B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 106.00 |
| Veradigm (MDRX) | United States | $0.517B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.498B | 0.00 |
| Standard BioTools (LAB) | United States | $0.465B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| Carlsmed (CARL) | United States | $0.327B | 0.00 |
| TruBridge (TBRG) | United States | $0.308B | 14.15 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.274B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.256B | 0.00 |
| CapsoVision (CV) | United States | $0.248B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.208B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.192B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.162B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.158B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.152B | 0.00 |
| CareCloud (CCLD) | United States | $0.132B | 7.23 |
| EUDA Health Holdings (EUDA) | Singapore | $0.103B | 0.00 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| Pulmonx (LUNG) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.043B | 0.00 |
| Precipio (PRPO) | United States | $0.037B | 0.00 |
| 111 (YI) | China | $0.034B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |